11.03.14
UPS has added cryogenic solutions to its temperature-sensitive shipping offerings with the introduction of Temperature True Cryo.
The service includes real-time tracking and intervention services, which, when combined with UPS’s monitoring, risk mitigation solutions and global network of control towers, is designed to provide complete visibility for cryogenic shipments at every stage of the supply chain journey.
The expansion is the latest addition to the UPS Temperature True suite of solutions and uses Cryoport’s cryogenic and related technologies, which allow UPS customers to use liquid nitrogen stored in dry vapor form to keep products frozen at -150°C for 10 days while in transit or storage, providing a reliable, safe container for cryopreservation of products.
“There is a growing spectrum of demand across tissue engineering, regenerative medicine, gene therapy, biopharmaceutical research and reproductive health, and we are excited to add UPS Temperature True Cryo to meet our clients’ needs,” said John Menna, UPS’s vice president of global strategy for healthcare logistics. “The value and irreplaceable nature of products requiring cryopreservation highlight the need for a combination of cryogenic capability and financial risk mitigation."
The service includes real-time tracking and intervention services, which, when combined with UPS’s monitoring, risk mitigation solutions and global network of control towers, is designed to provide complete visibility for cryogenic shipments at every stage of the supply chain journey.
The expansion is the latest addition to the UPS Temperature True suite of solutions and uses Cryoport’s cryogenic and related technologies, which allow UPS customers to use liquid nitrogen stored in dry vapor form to keep products frozen at -150°C for 10 days while in transit or storage, providing a reliable, safe container for cryopreservation of products.
“There is a growing spectrum of demand across tissue engineering, regenerative medicine, gene therapy, biopharmaceutical research and reproductive health, and we are excited to add UPS Temperature True Cryo to meet our clients’ needs,” said John Menna, UPS’s vice president of global strategy for healthcare logistics. “The value and irreplaceable nature of products requiring cryopreservation highlight the need for a combination of cryogenic capability and financial risk mitigation."